Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. - Wikidata - awgldk - TriplyDB

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

http://www.wikidata.org/entity/Q34176834

about

Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction Invasive urodynamic studies for the management of LUTS in men with voiding dysfunction Recent advances in treatment for Benign Prostatic Hyperplasia Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study.Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model Lower urinary tract symptoms: thinking beyond the urinary tract.The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.Medical attendance for lower urinary tract symptoms is associated with subsequent increased risk of outpatient visits and hospitalizations based on a nationwide population-based database.A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area.The Relationship between Depression, Anxiety, Somatization, Personality and Symptoms of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up.Depression and Its Severity Are Strongly Associated with Both Storage and Voiding Lower Urinary Tract Symptoms Independently of Prostate Volume.The Differential Expression and Function of the Inflammatory Chemokine Receptor CXCR5 in Benign Prostatic Hyperplasia and Prostate Cancer Men With Severe Lower Urinary Tract Symptoms Are at Increased Risk of Depression NF-κB and androgen receptor variant expression correlate with human BPH progression NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis.Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi-centre study.Are lower urinary tract symptoms in men associated with cardiovascular diseases in a primary care population: a registry study.Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.Factors related to receipt of non-cancer-related transurethral prostatectomy: findings from a large prospective study of 106 769 middle-aged and older Australian men Testosterone deficiency, cardiac health, and older men.Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case series.Non-Hormonal treatment of BPH/BOO Nonsteroidal anti-inflammatory drugs and prostatic diseases Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in men with diabetes mellitus Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons.Dietary Antioxidants and Longitudinal Changes in Lower Urinary Tract Symptoms in Elderly Men: The Osteoporotic Fractures in Men Study.Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.Bacteriological Profile of Isolates From Urine Samples in Patients of Benign Prostatic Hyperplasia and or Prostatitis Showing Lower Urinary Tract Symptoms.

P2860

Q24186369-B6B30707-D9E4-44B7-947B-53A07FAA40FA Q24194219-3B6A58CE-2459-4DEA-8829-03AFAB276D1E Q26766218-35FC25A6-E8E2-48A4-BEFC-63CF481E42CB Q26785752-1EE99472-5AA9-4ADE-8617-60F6262A7005 Q28082321-671B7680-40F2-4E21-AB04-A86E77C44101 Q30432283-D5BAB491-1600-4529-848A-66C6F542B1A8 Q30525673-7CE16A97-1775-4B1C-892D-4CAC5BD3CAD2 Q31110115-800403E9-6F55-4482-831B-FF4E958B489D Q33908275-D0AC5AC5-F989-47E5-B9F2-52B3E07099F7 Q33956004-ACEE7740-AC9F-4436-B7F8-D14BF50D08EA Q34030026-48F0F33E-F5CD-4595-8C4B-FA50B688D4C8 Q34535741-A3677551-2026-41ED-BEA1-7B023982F6BE Q34614481-17D34FA8-C4F4-4478-8AA5-E3EEDB708ED7 Q34662522-86EC25B9-9F5F-4EF2-B689-63E4550612CF Q34962509-60C717E5-001A-45A5-B8A8-63AD1CB52920 Q35330693-E0064841-274D-4E5D-9DAD-B7AD98DBFF24 Q35687087-62A20E43-1649-427B-8C92-60F9FF59BE8A Q36146243-4CD7849F-D3B1-49AA-979D-9EEC25C3D8D3 Q36241740-1916258B-EDD7-4366-8632-74F152C663AC Q36274988-C964C728-F7F4-4C51-B3C2-DB86009F4284 Q36438266-068E7306-1338-41F8-B98E-A239D1D55D68 Q36606285-3937FE38-687F-4CC8-B6B8-C7FA560DB286 Q37018606-DDCB9661-9BCF-46E1-807B-A182D039B76B Q37060725-6000E494-986D-427F-AB7B-C25AD0A31135 Q37108885-99269074-524C-436A-8B56-CD30A87D45DF Q37466573-F712FED9-97F5-4C42-9FFF-1579C98221B9 Q37496451-1564E105-C832-4754-9D62-C1F57D048994 Q37502247-94A11D08-758A-45F9-8929-B601A2E3B129 Q37561605-7FDE6760-B1E4-4405-920E-98033FD3A724 Q37618958-BB744CEE-1A40-48E7-B33A-3125C7B3973E Q37639947-C71E1195-0BF6-4CE9-AFAC-B1D31DFE7764 Q37724941-94061D70-E7F2-4FF4-9684-C98B17FC27E0 Q38169997-DF53BE65-9E3C-416F-947C-B91A3DF08769 Q38205423-19CA2140-3E88-4900-86F0-38BF4EC11186 Q38217858-90EA2980-271A-43DF-8EE0-2A4E231DE22D Q38466768-F09F2354-38CD-4C0B-86B3-E89A63B5E960 Q38555382-67F7B4B4-065F-4FB4-9493-F342FCBF0E01 Q38672180-5434CFB8-3C31-4D12-843F-AE5753C0D827 Q38692706-43CD8D39-95CA-442B-A358-F5628066E58C Q39149948-7AF85E08-2398-480A-A0BE-77B5530AF053

P2860

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors.

http://www.wikidata.org/entity/Q34176834

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@ast

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@en

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@nl

type

label

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@ast

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@en

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@nl

prefLabel

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@ast

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@en

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@nl

P1433

Q34176834-801BFAB3-3CF8-464E-8B9A-3B27078B5EE6

P1476

Q34176834-F11D97A5-A81B-4658-A5E8-039DFAAA7B8A

P2093

Q34176834-F505BAF4-AF14-4C64-AB7F-CA06B7AA4EFA

P2860

Q34176834-012CF604-9E8F-43A4-9B02-476C1A896091

Q34176834-1340080A-BF67-4667-8096-370C8D6F4548

Q34176834-14E1B226-F172-4D77-B6D8-FEFCE4B49073

Q34176834-18851581-F68A-455A-BCB1-1201F682AF45

Q34176834-1963702F-CB0E-43AE-88E2-378214035EC8

Q34176834-1BEA681E-EB1B-436D-A544-F249011ABD99

Q34176834-27B0FA18-6DDE-45C6-AF5C-EC1E5A8185F7

Q34176834-2B3D9053-2923-4C9D-9E58-D518EA9BEA54

Q34176834-38071679-F7A7-4258-BA79-9B2065C3A365

Q34176834-3C80E3BE-0DE6-46E9-93F5-968B73E56D9D

P2888

Q34176834-D4FE16B1-8961-4073-866A-549C2B495EC6

P304

Q34176834-3B46CB9D-896B-49E4-AD3F-57C6B543AA63

P31

Q34176834-3ACA956C-EC8D-4C65-9E88-A65FFF19BDE0

P356

Q34176834-6FB300E8-27AA-4562-8A83-4E71AFD5B452

P433

Q34176834-24EB5A57-C011-4026-91A1-240EDEF9C302

P478

Q34176834-221D533A-D2DF-48E0-9567-D5F85465617D

P577

Q34176834-5DFC3EB2-2E4C-43B0-9C0F-5C35A76FA6DE

P5875

Q34176834-E15ECA7A-F7A9-491E-9D48-D4C5DB415D81

P6179

Q34176834-926C6262-AED9-4AA5-A49A-FC5CE9C98C4A

P698

Q34176834-8C04991C-371B-46CB-9E19-A9540BFF1B38

P921

Q34176834-0EE86801-E43D-44B9-9BAF-51F18BFA3800

P932

Q34176834-8F0B5FA0-33B4-4F8F-A6B1-19365D2E79C1

P356

S11884-010-0067-2

P1433

Current bladder dysfunction reports

P1476

Benign Prostatic Hyperplasia a ...... Epidemiology and Risk Factors.

@en

P2093

J Kellogg Parsons

http://www.w3.org/2001/XMLSchema#string

P2860

Increased oxidative stress in obesity and its impact on metabolic syndrome

Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms.

Asymptomatic inflammation and/or infection in benign prostatic hyperplasia.

Progression of lower urinary tract symptoms in older men: a community based study.

Lower urinary tract symptoms increase the risk of falls in older men

Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

Epidemic obesity and the metabolic syndrome.

Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans.

Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.

Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years.

P2888

s11884-010-0067-2

P304

212-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11884-010-0067-2

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51034875

http://www.w3.org/2001/XMLSchema#string

P6179

1034918489

http://www.w3.org/2001/XMLSchema#string

P698

21475707

http://www.w3.org/2001/XMLSchema#string

P921

P932

3061630

http://www.w3.org/2001/XMLSchema#string